Search
Niagen Bioscience Inc
NAGEAdd to Watchlist
2.070USD
0.0000.00%
Close 11-06 16:00（ET）
163.80MMarket Cap
8.86P/E TTM
Niagen Bioscience Inc (NAGE) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Niagen Bioscience Inc in the past month.
Buy
2 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
11.917USD+411.45%
NAGE Analyst Recommendation Trends
In the current month, NAGE has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NAGE average Analyst price target in the last month is 11.917.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
2
2
2
2
4
4
4
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
5
5
5
5
5
NAGE Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, NAGE EPS is projected to reach 0.010 in FY2026Q4, following reported EPS of -0.015 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.07
0.01
0.00
0.01
0.01
Actual
0.08
0.01
-0.01
--
--
Surprise
+16.26%
-19.07%
-987.43%
--
--
FAQs
What is Niagen Bioscience Inc's expected revenue for the next quarter?
Niagen Bioscience Inc's expected revenue is 35.09M.
What is Niagen Bioscience Inc's price target?
Analysts forecast that Niagen Bioscience Inc's price target is USD 11.75, with the highest forecast at USD 22.00 and the lowest forecast at USD 8.50.
How have Niagen Bioscience IncNAGE's recent earnings per share performed?
The market expectation was USD -0.01, while Niagen Bioscience IncNAGE's earnings per share (EPS) for the previous quarter was USD 0.01. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for Niagen Bioscience Inc?
Based on the ratings of Niagen Bioscience Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.